Category: Becton Dickinson & Co.
Here's a look at some of the top legal news stories for medical device companies this week: Supreme Court passes on Mirowski-Medtronic patent case; Medtronic can't shake shareholders lawsuit over Infuse; FDA strikes out again in Prevor drug-or-device case; Ex-Bard, BD engineer gets 18 months for stealing trade secrets; Appeals court: Fujifilm Medical executive wasn't fired for not being Japanese
A former engineer for Becton, Dickinson & Co. and C.R. Bard who confessed to stealing trade secrets concerning an injector pen is sentenced to 18 months in prison.
BD has acquired GenCell Biosystems, an Irish startup with a system to automate the creation of "libraries" that help scientists sequence gene information, while reportedly cutting jobs in California.
Here's a look at some of the top legal news stories for medical device companies this week: Shareholder sues Medtronic over plan to cover execs' $58m tax tab; Report: Bard's mesh settlement is worth $21m; Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower; BD loses bid to overturn $114m antitrust loss to Retractable Technologies; Ex-Oriole DeCinces fights insider trading charges
Here's a look at some of the top Wall Street stories for medical device companies this week: Wall Street loves Edwards Lifesciences again; Becton Dickinson to buy CareFusion for $12 billion in cash, stock; Proxy war rages on at Echo Therapeutics; Platinum fires back at Echo Therapeutics over 'rogue' directors; Echo Therapeutics hits back at Platinum Equity
Becton Dickinson is on the hook for a $114 million antitrust verdict after a federal judge declines its bid to overturn the decision.
What does news of yet another mega-merger mean for medtech's industry council?
The winds of change in medtech are blowing in the Windy City.
As medtech's best & brightest descended on Chicago for another annual confab at AdvaMed 2014, it was impossible to ignore that the industry has now entered the great age of consolidation with yet another multibillion-dollar healthcare deal.